No shortage on file

TRI-JORDYNA 21

GLENMARK PHARMACEUTICALS CANADA INC.

Quick answers

Is there a shortage of TRI-JORDYNA 21 in Canada?

No. There is no current shortage of TRI-JORDYNA 21 0.25MG 0.18MG 0.215MG 0.035MG 0.035MG 0.035MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on fileNone found

DIN

02486296

Strength

0.25MG 0.18MG 0.215MG 0.035MG 0.035MG 0.035MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

NORGESTIMATE ETHINYL ESTRADIOL

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

2026-06-24

Resolved

Demand increase for the drug.

Other Products from GLENMARK PHARMACEUTICALS CANADA INC.

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS

DIN 02466783

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP

DIN 02462060

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 21

DIN 02421437

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 28

DIN 02421445

GLN-APREMILAST

30MG · DIN 02518910

GLN-ATOVAQUONE

750MG · DIN 02528495